The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFeedback Regulatory News (FDBK)

Share Price Information for Feedback (FDBK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 82.50
Bid: 80.00
Ask: 85.00
Change: 0.00 (0.00%)
Spread: 5.00 (6.25%)
Open: 82.50
High: 82.50
Low: 82.50
Prev. Close: 82.50
FDBK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update re Bleepa®

17 Oct 2019 07:00

RNS Number : 1508Q
Feedback PLC
17 October 2019
 

Feedback plc

 

Update re Bleepa® 

 

Cambridge, 17 October 2019: Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the specialist medical imaging technology company, is pleased to provide an update on Bleepa®.

 

The Company is considering a number of potential opportunities for Bleepa® following its launch at the NHS Expo in September 2019. The Company is in advanced discussions with NHS pilot sites whilst additionally pursuing a number of commercial opportunities within and outside the NHS, and hopes to commence Bleepa® pilot schemes in the near future.

 

To date, the Bleepa® product has been well received by the healthcare community and the Company believes that it will enable a number of healthcare providers to provide faster, safer, more efficient care. The Company looks forward to providing further updates in due course.

 

Tom Oakley, CEO of Feedback plc, said:

 

"We are very encouraged by the response to Bleepa® having discussed this with senior NHS executives and clinicians at NHS Expo. The feedback that we have received is that Bleepa® clearly has applications across the healthcare sector, not only in individual hospital settings but also in community and cross site clinical settings. We look forward to making further announcements in relation to Bleepa®, in due course."

 

The Company continues to progress with its strategic review of TexRAD®, a longstanding part of the Feedback portfolio. The Company hopes to complete the strategic review by the end of the calendar year.

 

-Ends-

Enquiries:

 

Feedback plc

Tom Oakley, CEO

Lindsay Melvin, CFO

+44 (0)1954 718072

IR@fbk.com

Allenby Capital Limited (Nominated Adviser)

David Worlidge / Asha Chotai

+44 (0)20 3328 5656

Peterhouse Capital Limited (Joint Broker)

Lucy Williams / Duncan Vasey

 

+44 (0)20 7469 0936

Stanford Capital Partners Limited (Joint Broker)

Patrick Claridge / John Howes

+44 20 3815 8880

 

Instinctif Partners

Rozi Morris / Phillip Marriage

+44 (0)20 7457 2020

feedbackplc@instinctif.com

 

 

Notes to editors

 

About Feedback plc - www.fbk.com

Feedback plc (AIM: FDBK) is a specialist medical imaging technology company providing innovative software and systems, through its fully-owned trading subsidiary, Feedback Medical Limited. Its products advance the work of radiologists, clinicians and medical researchers by improving workflows and giving unique insights into diseases, particularly cancer.

 

Feedback has launched Bleepa®, a new secure, encrypted medical communication app for clinicians accessible through smartphones, tablets and desktops that facilitates rapid clinical messaging and review of medical grade imaging for all members of a clinical team, directly from a hospital Picture Archiving and Communications System (PACS). For more information on Bleepa®, see www.bleepa.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDMFBLTMBIBBFL
Date   Source Headline
1st Oct 20187:00 amRNSAppointment of Joint Broker
10th Sep 20187:00 amRNSTexRAD® ordered by Samsung Medical Centre in Seoul
17th Aug 20182:02 pmRNSDirector/PDMR Shareholding
15th Aug 20187:00 amRNSFirst GE Healthcare order for TexRAD®
1st Aug 20181:19 pmRNSDirector/PDMR Shareholding
20th Jul 20187:00 amRNSDirectorate Change
6th Jul 20187:00 amRNSJoint broker update
29th Jun 20183:20 pmRNSDirector/PDMR Shareholding
27th Jun 20187:00 amRNSGrant of Options and Director/PDMR Dealing
22nd Jun 20182:10 pmRNSResult of General Meeting
8th Jun 201810:36 amRNSHolding(s) in Company
7th Jun 20187:05 amRNSNotice of General Meeting
7th Jun 20187:00 amRNSRevised strategy to build a global company
1st Jun 20187:00 amRNSAppointment of new Medical Director
10th May 20189:27 amRNSHolding(s) in Company
4th May 20186:09 pmRNSHolding(s) in Company
1st May 20187:00 amRNSDirector/PDMR Shareholding
30th Apr 20185:00 pmRNSTotal Voting Rights
27th Apr 20187:00 amRNSTwo-year contract with Royal Papworth Hospital
25th Apr 20182:05 pmRNSSecond Price Monitoring Extn
25th Apr 20182:00 pmRNSPrice Monitoring Extension
25th Apr 20187:00 amRNSDistribution agreement with GE Healthcare
17th Apr 20187:00 amRNSHolding(s) in Company
16th Apr 20187:30 amRNSNew Company Structure and Directorate Change
16th Apr 20187:25 amRNSAppointment of non-executive director
9th Apr 20182:39 pmRNSHolding(s) in Company
29th Mar 20187:00 amRNSEquity Fundraising to raise £440,000
21st Mar 20189:01 amRNSHolding(s) in Company
16th Mar 20185:11 pmRNSHolding(s) in Company
16th Mar 20187:00 amRNSDirectorate Change
8th Mar 20188:48 amRNSHolding(s) in Company
7th Mar 20182:39 pmRNSHolding(s) in Company
1st Mar 20181:03 pmRNSHolding(s) in Company
26th Feb 20187:00 amRNSHalf-year Report
14th Feb 20187:00 amRNSDirectorate Change
9th Feb 201812:04 pmRNSHolding(s) in Company
5th Feb 20181:56 pmRNSHolding(s) in Company
28th Dec 20175:42 pmRNSHolding(s) in Company
28th Dec 20175:19 pmRNSTotal Voting Rights
20th Dec 20179:33 amRNSHolding(s) in Company
30th Nov 20174:38 pmRNSResult of AGM
22nd Nov 20179:37 amRNSHolding(s) in Company
22nd Nov 20177:00 amRNSPresentation at RSNA 2017
20th Nov 201712:40 pmRNSHolding(s) in Company
20th Nov 20177:00 amRNSFirst CE marked release of TexRAD® technology
7th Nov 20177:00 amRNSFinal Results
14th Sep 20177:00 amRNSHolding(s) in Company
31st Jul 20175:00 pmRNSTotal Voting Rights
28th Jul 201710:53 amRNSCCI Exclusive Distributor agreement with Boya
30th Jun 20172:21 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.